» Articles » PMID: 37115046

Mortality and Risk Factors Associated with Peptic Ulcer Bleeding Among Adult Inpatients of Damascus Hospital, Syria: A Cross-sectional Study

Overview
Specialty General Medicine
Date 2023 Apr 28
PMID 37115046
Authors
Affiliations
Soon will be listed here.
Abstract

Peptic ulcer bleeding is associated with significant morbidity and mortality, while monitoring mortality is extremely beneficial to public health, and the latest estimates date back to 2010 for the Syrian population. This study aims to estimate the in-hospital mortality rate and risk factors associated with peptic ulcer bleeding among adult inpatients at Damascus Hospital, Syria. A cross-sectional study with systematic random sampling. Sample size (n) was calculated using the proportional equation: [n = Z2P (1 - P)/d2], with the following hypothesis: Z = 1.96 for the 95% confidence level, P = .253 for mortality in patients hospitalized with complicated peptic ulcers, a margin of error (d) = 0.05, 290 charts were reviewed, and the Chi-square test (χ2 test) was used for categorical variables, and the t test for continuous data. We reported the odds ratio in addition to mean and standard deviation with a 95% confidence. A P value less than .05 was considered statistically significant. Data were analyzed using a statistical package for the social sciences (SPSS). The mortality rate was 3.4%, and the mean age was 61.76 ± 16.02 years. The most frequent comorbidities were hypertension, diabetes mellitus, and ischemic heart disease. The most commonly used medications were NSAIDs, aspirin, and clopidogrel. 74 patients (25.52%) were using aspirin with no documented indication P < .01, odds ratio = 6.541, 95% CI [2.612-11.844]. There were 162 (56%) Smokers. Six patients (2.1%) suffered from recurrent bleeding, and 13 (4.5%) needed surgery. Raising awareness about the risks of using non-steroidal anti-inflammatory drugs may reduce the occurrence of peptic ulcers and, as a result, peptic ulcer complications. Larger, nationwide studies are needed to estimate the real mortality rate in complicated peptic ulcer patients in Syria. There is a lack of some critical data in the patients' charts, which necessitates action to correct.

Citing Articles

Use of as a gastroprotective and anti-inflammatory agent on indomethacin-induced gastric ulcers in obese rats.

Pinon-Simental J, Ayala-Ruiz L, Ortega-Perez L, Magana-Rodriguez O, Melendez-Herrera E, Aguilera-Mendez A PeerJ. 2024; 12:e17062.

PMID: 38435992 PMC: 10908265. DOI: 10.7717/peerj.17062.


Endoscopic Vacuum-Assisted Closure (E-VAC) in Septic Shock from Perforated Duodenal Ulcers with Abscess Formations.

Ciuntu B, Tanevski A, Buescu D, Lutenco V, Mihailov R, Ciuntu M J Clin Med. 2024; 13(2).

PMID: 38256604 PMC: 10816729. DOI: 10.3390/jcm13020470.

References
1.
Lin K, Garcia Rodriguez L, Hernandez-Diaz S . Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?. Pharmacoepidemiol Drug Saf. 2011; 20(7):718-28. DOI: 10.1002/pds.2153. View

2.
Papatheodoridis G, Sougioultzis S, Archimandritis A . Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol. 2006; 4(2):130-42. DOI: 10.1016/j.cgh.2005.10.006. View

3.
Chey W, Leontiadis G, Howden C, Moss S . ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017; 112(2):212-239. DOI: 10.1038/ajg.2016.563. View

4.
Elfil M, Negida A . Sampling methods in Clinical Research; an Educational Review. Emerg (Tehran). 2017; 5(1):e52. PMC: 5325924. View

5.
Thomsen R, Riis A, Christensen S, Norgaard M, Sorensen H . Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care. 2006; 29(4):805-10. DOI: 10.2337/diacare.29.04.06.dc05-1748. View